Selumetinib

Last Updated: 03/28/17

Status: Currently a NF2 Clinical Trial

Index

  • NF2 Related Trials
  • Treatment Information
  • Also Treatment For
  • Patents

Selumetinib (AZD6244) is a drug being investigated for the treatment of various types of cancer, for example non-small cell lung cancer (NSCLC). - Wikipedia

Trade Name N/A
Other Names AZD 6244, 606143-52-6, AZD6244, AZD-6244, ARRY-142886, CHEMBL1614701, NCGC00189073-01, PubChem21092, Selumetinib (USAN/INN)
Pharmaceutical Company N/A
Inhibitor MAPK/ERK Pathway
Selumetinib blocks the subtypes MEK1 and MEK2 of the MAPK kinase (MEK) enzyme.
Molecular Formula C17H15BrClFN4O3
IUPAC 6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
ChemSpider 8303141 (accessed 16:29, Oct 11, 2012)
PubChem CID 10127622

Treatment Information

UK Treatments: The role of insulin-like growth factors signaling in merlin-deficient human schwannomas


Also Treatment For

  • Thyroid Cancer
  • Melanoma
  • Colorectal Cancer
  • Ovarian Cancer

Patents

Top 5 of 19 Treatments
Patent # Date Title
US20100260714A1 6-4-2012 COMPOSITIONS COMPRISING N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS AND METHODS OF USE THEREOF COMPOSITIONS COMPRISING N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS AND METHODS OF USE THEREOF
US20100267793A1 6-4-2012 METHOD OF TREATMENT USING N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS METHOD OF TREATMENT USING N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS
US20100261718A1 5-14-2012 N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS
US20100261717A1 8-22-2011 N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS
US20100267710A1 7-4-2011 N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS


What is NF2? | About Us | Treatment Options | Sitemap

Disclaimer: Neurofibromatosis Type 2 - Information and Services, www.nf2is.org, is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. - Read More

Copyright © 2008 - 2017